New study: could a Half-Matched transplant beat drugs for severe anemia?
NCT ID NCT07338422
First seen Jan 19, 2026 · Last updated May 25, 2026 · Updated 19 times
Summary
This study compares two first-line treatments for severe aplastic anemia (SAA) in patients without a fully matched donor: a half-matched stem cell transplant (from a family member) versus strong immune-suppressing drugs. About 116 people aged 14-70 will be followed to see which approach leads to better survival and recovery. The goal is to find the safest and most effective initial therapy for this serious blood disorder.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for APLASTIC ANAEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.